 | • レポートコード：QYR9N7610 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、重症筋無力症の治療のグローバル市場について調査・分析したレポートで、種類別（重症筋無力症、先天性重症筋無力症、全身性重症筋無力症、一過性重症筋無力症、その他）、用途別（病院と診療所、診断センター、学術研究機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・重症筋無力症の治療の世界市場規模 ・主要企業別市場シェア ・重症筋無力症の治療の世界市場規模：種類別（重症筋無力症、先天性重症筋無力症、全身性重症筋無力症、一過性重症筋無力症、その他） ・重症筋無力症の治療の世界市場規模：用途別（病院と診療所、診断センター、学術研究機関） ・重症筋無力症の治療のアメリカ市場規模（種類別、用途別） ・重症筋無力症の治療のヨーロッパ市場規模（種類別、用途別） ・重症筋無力症の治療の中国市場規模（種類別、用途別） ・重症筋無力症の治療の日本市場規模（種類別、用途別） ・重症筋無力症の治療の東南アジア市場規模（種類別、用途別） ・重症筋無力症の治療のインド市場規模（種類別、用途別） ・重症筋無力症の治療の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・重症筋無力症の治療の世界市場予測（2019年-2025年） ・重症筋無力症の治療の地域別市場予測（2019年-2025年） ... |
Myasthenia gravis is a chronic autoimmune neuromuscular disease that causes weakness in the skeletal muscles, which are responsible for breathing and moving parts of the body, including the arms and legs.In 2018, the global Myasthenia Gravis Therapies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Myasthenia Gravis Therapies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Myasthenia Gravis Therapies development in United States, Europe and China.
The key players covered in this study
Alexion Pharmaceuticals
Novartis
CSL Behring
Grifols
…
Market segment by Type, the product can be split into
Ocular Myasthenia Gravis
Congenital Myasthenia Gravis
Generalized Myasthenia Gravis
Transient Myasthenia Gravis
Others
Market segment by Application, split into
Hospitals and Clinics
Diagnostic Centers
Academic and Research Organizations
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Myasthenia Gravis Therapies status, future forecast, growth opportunity, key market and key players.
To present the Myasthenia Gravis Therapies development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Myasthenia Gravis Therapies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Myasthenia Gravis Therapies Market Size Growth Rate by Type (2014-2025)
1.4.2 Ocular Myasthenia Gravis
1.4.3 Congenital Myasthenia Gravis
1.4.4 Generalized Myasthenia Gravis
1.4.5 Transient Myasthenia Gravis
1.4.6 Others
1.5 Market by Application
1.5.1 Global Myasthenia Gravis Therapies Market Share by Application (2014-2025)
1.5.2 Hospitals and Clinics
1.5.3 Diagnostic Centers
1.5.4 Academic and Research Organizations
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Myasthenia Gravis Therapies Market Size
2.2 Myasthenia Gravis Therapies Growth Trends by Regions
2.2.1 Myasthenia Gravis Therapies Market Size by Regions (2014-2025)
2.2.2 Myasthenia Gravis Therapies Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Myasthenia Gravis Therapies Market Size by Manufacturers
3.1.1 Global Myasthenia Gravis Therapies Revenue by Manufacturers (2014-2019)
3.1.2 Global Myasthenia Gravis Therapies Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Myasthenia Gravis Therapies Market Concentration Ratio (CR5 and HHI)
3.2 Myasthenia Gravis Therapies Key Players Head office and Area Served
3.3 Key Players Myasthenia Gravis Therapies Product/Solution/Service
3.4 Date of Enter into Myasthenia Gravis Therapies Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Myasthenia Gravis Therapies Market Size by Type (2014-2019)
4.2 Global Myasthenia Gravis Therapies Market Size by Application (2014-2019)
5 United States
5.1 United States Myasthenia Gravis Therapies Market Size (2014-2019)
5.2 Myasthenia Gravis Therapies Key Players in United States
5.3 United States Myasthenia Gravis Therapies Market Size by Type
5.4 United States Myasthenia Gravis Therapies Market Size by Application
6 Europe
6.1 Europe Myasthenia Gravis Therapies Market Size (2014-2019)
6.2 Myasthenia Gravis Therapies Key Players in Europe
6.3 Europe Myasthenia Gravis Therapies Market Size by Type
6.4 Europe Myasthenia Gravis Therapies Market Size by Application
7 China
7.1 China Myasthenia Gravis Therapies Market Size (2014-2019)
7.2 Myasthenia Gravis Therapies Key Players in China
7.3 China Myasthenia Gravis Therapies Market Size by Type
7.4 China Myasthenia Gravis Therapies Market Size by Application
8 Japan
8.1 Japan Myasthenia Gravis Therapies Market Size (2014-2019)
8.2 Myasthenia Gravis Therapies Key Players in Japan
8.3 Japan Myasthenia Gravis Therapies Market Size by Type
8.4 Japan Myasthenia Gravis Therapies Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Myasthenia Gravis Therapies Market Size (2014-2019)
9.2 Myasthenia Gravis Therapies Key Players in Southeast Asia
9.3 Southeast Asia Myasthenia Gravis Therapies Market Size by Type
9.4 Southeast Asia Myasthenia Gravis Therapies Market Size by Application
10 India
10.1 India Myasthenia Gravis Therapies Market Size (2014-2019)
10.2 Myasthenia Gravis Therapies Key Players in India
10.3 India Myasthenia Gravis Therapies Market Size by Type
10.4 India Myasthenia Gravis Therapies Market Size by Application
11 Central & South America
11.1 Central & South America Myasthenia Gravis Therapies Market Size (2014-2019)
11.2 Myasthenia Gravis Therapies Key Players in Central & South America
11.3 Central & South America Myasthenia Gravis Therapies Market Size by Type
11.4 Central & South America Myasthenia Gravis Therapies Market Size by Application
12 International Players Profiles
12.1 Alexion Pharmaceuticals
12.1.1 Alexion Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Myasthenia Gravis Therapies Introduction
12.1.4 Alexion Pharmaceuticals Revenue in Myasthenia Gravis Therapies Business (2014-2019)
12.1.5 Alexion Pharmaceuticals Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Myasthenia Gravis Therapies Introduction
12.2.4 Novartis Revenue in Myasthenia Gravis Therapies Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 CSL Behring
12.3.1 CSL Behring Company Details
12.3.2 Company Description and Business Overview
12.3.3 Myasthenia Gravis Therapies Introduction
12.3.4 CSL Behring Revenue in Myasthenia Gravis Therapies Business (2014-2019)
12.3.5 CSL Behring Recent Development
12.4 Grifols
12.4.1 Grifols Company Details
12.4.2 Company Description and Business Overview
12.4.3 Myasthenia Gravis Therapies Introduction
12.4.4 Grifols Revenue in Myasthenia Gravis Therapies Business (2014-2019)
12.4.5 Grifols Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Myasthenia Gravis Therapies Key Market Segments
Table Key Players Myasthenia Gravis Therapies Covered
Table Global Myasthenia Gravis Therapies Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Myasthenia Gravis Therapies Market Size Market Share by Type 2014-2025
Figure Ocular Myasthenia Gravis Figures
Table Key Players of Ocular Myasthenia Gravis
Figure Congenital Myasthenia Gravis Figures
Table Key Players of Congenital Myasthenia Gravis
Figure Generalized Myasthenia Gravis Figures
Table Key Players of Generalized Myasthenia Gravis
Figure Transient Myasthenia Gravis Figures
Table Key Players of Transient Myasthenia Gravis
Figure Others Figures
Table Key Players of Others
Table Global Myasthenia Gravis Therapies Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals and Clinics Case Studies
Figure Diagnostic Centers Case Studies
Figure Academic and Research Organizations Case Studies
Figure Myasthenia Gravis Therapies Report Years Considered
Table Global Myasthenia Gravis Therapies Market Size 2014-2025 (Million US$)
Figure Global Myasthenia Gravis Therapies Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Myasthenia Gravis Therapies Market Size by Regions 2014-2025 (Million US$)
Table Global Myasthenia Gravis Therapies Market Size by Regions 2014-2019 (Million US$)
Table Global Myasthenia Gravis Therapies Market Share by Regions 2014-2019
Figure Global Myasthenia Gravis Therapies Market Share by Regions 2014-2019
Figure Global Myasthenia Gravis Therapies Market Share by Regions 2019
Table Market Top Trends
Table Global Myasthenia Gravis Therapies Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Myasthenia Gravis Therapies Market Share by Manufacturers (2014-2019)
Figure Global Myasthenia Gravis Therapies Market Share by Manufacturers in 2018
Table Global Myasthenia Gravis Therapies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Myasthenia Gravis Therapies Product/Solution/Service
Table Date of Enter into Myasthenia Gravis Therapies Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Myasthenia Gravis Therapies Market Size by Type (2014-2019) (Million US$)
Table Global Myasthenia Gravis Therapies Market Size Share by Type (2014-2019)
Figure Global Myasthenia Gravis Therapies Market Size Market Share by Type (2014-2019)
Table Global Myasthenia Gravis Therapies Market Size by Application (2014-2019) (Million US$)
Table Global Myasthenia Gravis Therapies Market Size Share by Application (2014-2019)
Figure Global Myasthenia Gravis Therapies Market Size Market Share by Application (2014-2019)
Figure Global Myasthenia Gravis Therapies Revenue Market Share by Application in 2018
Figure United States Myasthenia Gravis Therapies Market Size 2014-2019 (Million US$)
Table United States Key Players Myasthenia Gravis Therapies Revenue (2018-2019) (Million US$)
Table United States Key Players Myasthenia Gravis Therapies Market Share (2018-2019)
Table United States Myasthenia Gravis Therapies Market Size by Type (2014-2019) (Million US$)
Table United States Myasthenia Gravis Therapies Market Share by Type (2014-2019)
Table United States Myasthenia Gravis Therapies Market Size by Application (2014-2019) (Million US$)
Table United States Myasthenia Gravis Therapies Market Share by Application (2014-2019)
Figure Europe Myasthenia Gravis Therapies Market Size 2014-2019 (Million US$)
Table Europe Key Players Myasthenia Gravis Therapies Revenue (2018-2019) (Million US$)
Table Europe Key Players Myasthenia Gravis Therapies Market Share (2018-2019)
Table Europe Myasthenia Gravis Therapies Market Size by Type (2014-2019) (Million US$)
Table Europe Myasthenia Gravis Therapies Market Share by Type (2014-2019)
Table Europe Myasthenia Gravis Therapies Market Size by Application (2014-2019) (Million US$)
Table Europe Myasthenia Gravis Therapies Market Share by Application (2014-2019)
Figure China Myasthenia Gravis Therapies Market Size 2014-2019 (Million US$)
Table China Key Players Myasthenia Gravis Therapies Revenue (2018-2019) (Million US$)
Table China Key Players Myasthenia Gravis Therapies Market Share (2018-2019)
Table China Myasthenia Gravis Therapies Market Size by Type (2014-20189) (Million US$)
Table China Myasthenia Gravis Therapies Market Share by Type (2014-2019)
Table China Myasthenia Gravis Therapies Market Size by Application (2014-2019) (Million US$)
Table China Myasthenia Gravis Therapies Market Share by Application (2014-2019)
Figure Japan Myasthenia Gravis Therapies Market Size 2014-2019 (Million US$)
Table Japan Key Players Myasthenia Gravis Therapies Revenue (2018-2019) (Million US$)
Table Japan Key Players Myasthenia Gravis Therapies Market Share (2018-2019)
Table Japan Myasthenia Gravis Therapies Market Size by Type (2014-2019) (Million US$)
Table Japan Myasthenia Gravis Therapies Market Share by Type (2014-2019)
Table Japan Myasthenia Gravis Therapies Market Size by Application (2014-2019) (Million US$)
Table Japan Myasthenia Gravis Therapies Market Share by Application (2014-2019)
Figure Southeast Asia Myasthenia Gravis Therapies Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Myasthenia Gravis Therapies Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Myasthenia Gravis Therapies Market Share (2018-2019)
Table Southeast Asia Myasthenia Gravis Therapies Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Myasthenia Gravis Therapies Market Share by Type (2014-2019)
Table Southeast Asia Myasthenia Gravis Therapies Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Myasthenia Gravis Therapies Market Share by Application (2014-2019)
Figure India Myasthenia Gravis Therapies Market Size 2014-2019 (Million US$)
Table India Key Players Myasthenia Gravis Therapies Revenue (2018-2019) (Million US$)
Table India Key Players Myasthenia Gravis Therapies Market Share (2018-2019)
Table India Myasthenia Gravis Therapies Market Size by Type (2014-2019) (Million US$)
Table India Myasthenia Gravis Therapies Market Share by Type (2014-2019)
Table India Myasthenia Gravis Therapies Market Size by Application (2014-2019) (Million US$)
Table India Myasthenia Gravis Therapies Market Share by Application (2014-2019)
Figure Central & South America Myasthenia Gravis Therapies Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Myasthenia Gravis Therapies Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Myasthenia Gravis Therapies Market Share (2018-2019)
Table Central & South America Myasthenia Gravis Therapies Market Size by Type (2014-2019) (Million US$)
Table Central & South America Myasthenia Gravis Therapies Market Share by Type (2014-2019)
Table Central & South America Myasthenia Gravis Therapies Market Size by Application (2014-2019) (Million US$)
Table Central & South America Myasthenia Gravis Therapies Market Share by Application (2014-2019)
Table Alexion Pharmaceuticals Company Details
Table Alexion Pharmaceuticals Revenue in Myasthenia Gravis Therapies Business (2014-2019) (Million US$)
Figure Alexion Pharmaceuticals Revenue Growth Rate in Myasthenia Gravis Therapies Business (2014-2019)
Table Alexion Pharmaceuticals Recent Development
Table Novartis Company Details
Table Novartis Revenue in Myasthenia Gravis Therapies Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Myasthenia Gravis Therapies Business (2014-2019)
Table Novartis Recent Development
Table CSL Behring Company Details
Table CSL Behring Revenue in Myasthenia Gravis Therapies Business (2014-2019)(Million US$)
Figure CSL Behring Revenue Growth Rate in Myasthenia Gravis Therapies Business (2014-2019)
Table CSL Behring Recent Development
Table Grifols Company Details
Table Grifols Revenue in Myasthenia Gravis Therapies Business (2014-2019)(Million US$)
Figure Grifols Revenue Growth Rate in Myasthenia Gravis Therapies Business (2014-2019)
Table Grifols Recent Development
Table Global Myasthenia Gravis Therapies Market Size by Regions (Million US$) 2019-2025
Figure Global Myasthenia Gravis Therapies Market Size Share by Regions (2019-2025)
Figure Global Myasthenia Gravis Therapies Market Size Share by Regions in 2025
Figure United States Myasthenia Gravis Therapies Market Size Forecast (2019-2025)(Million USD)
Figure Europe Myasthenia Gravis Therapies Market Size Forecast (2019-2025)(Million USD)
Figure China Myasthenia Gravis Therapies Market Size Forecast (2019-2025)(Million USD)
Figure Japan Myasthenia Gravis Therapies Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Myasthenia Gravis Therapies Market Size Forecast (2019-2025)(Million USD)
Figure India Myasthenia Gravis Therapies Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Myasthenia Gravis Therapies Market Size Forecast (2019-2025)(Million USD)
Table Global Myasthenia Gravis Therapies Market Size by Product (2019-2025) (Million US$)
Figure Global Myasthenia Gravis Therapies Market Size by Product (2019-2025)
Figure Global Myasthenia Gravis Therapies Market Size by Product in 2025
Table Global Myasthenia Gravis Therapies Market Size by Application (2019-2025) (Million US$)
Figure Global Myasthenia Gravis Therapies Market Size by Application (2019-2025)
Figure Global Myasthenia Gravis Therapies Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の重症筋無力症市場：市場規模・現状・予測 In 2018, the global Myasthenia Gravis market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Myasthenia Gravis status, future forecast, growth opportunity, key market and key players. The study object…- 世界の緑内障レーザー治療市場：市場規模・現状・予測 SLT (glaucoma laser therapies) provides the benefits of argon laser trabeculoplasty without the coagulative damage that leads to scarring.In 2018, the global Glaucoma Laser Therapies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% duri…
- 世界の緑内障手術療法市場：市場規模・現状・予測 Surgery involves either laser treatment or making a cut in the eye to reduce the intraocular pressure. The type of surgery your doctor recommends will depend on the type and severity of your glaucoma and the general health of your eye.In 2018, the global Glaucoma Surgery Therapies market size was xx…
- 世界の血液学療法市場：市場規模・現状・予測 Hematology is a branch of medicine concerned with the study of blood, blood disease and the organs involved in forming blood.In 2018, the global Hematology Therapies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. Thi…
- 世界の精密がん治療市場：市場規模・現状・予測 Precision cancer therapies is an evolving approach to cancer care that aims to leverage new knowledge regarding the pathogenesis of cancer to more precisely target therapy.Precision cancer medicine utilizes molecular diagnostic testing, including DNA sequencing, to identify cancer-driving abnormalit…